Marshall Wace, LLP Nkarta, Inc. Transaction History
Marshall Wace, LLP
- $72.2 Billion
- Q2 2024
A detailed history of Marshall Wace, LLP transactions in Nkarta, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 439,973 shares of NKTX stock, worth $1.99 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
439,973
Previous 185,869
136.71%
Holding current value
$1.99 Million
Previous $2.01 Million
29.42%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding NKTX
# of Institutions
120Shares Held
66.2MCall Options Held
142KPut Options Held
43.1K-
Ra Capital Management, L.P. Boston, MA10.8MShares$48.8 Million0.96% of portfolio
-
Boxer Capital, LLC San Diego, CA5.61MShares$25.3 Million1.84% of portfolio
-
Commodore Capital LP New York, NY4.15MShares$18.8 Million2.2% of portfolio
-
Black Rock Inc. New York, NY4.06MShares$18.3 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.8MShares$17.2 Million0.47% of portfolio
About Nkarta, Inc.
- Ticker NKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,656,800
- Market Cap $220M
- Description
- Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...